As of 2026-06-10, the EV/EBITDA ratio of Solasia Pharma KK (4597.T) is -5.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 4597.T's latest enterprise value is 4,805.43 mil JPY. 4597.T's TTM EBITDA according to its financial statements is -834.00 mil JPY. Dividing these 2 quantities gives us the above 4597.T EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 15.2x | 9.3x |
| Forward P/E multiples | 12.4x - 16.3x | 15.8x |
| Fair Price | (32.28) - (41.00) | (32.86) |
| Upside | -240.3% - -278.3% | -242.9% |
| Date | EV/EBITDA |
| 2026-06-05 | -5.76 |
| 2026-06-04 | -5.43 |
| 2026-06-03 | -6.09 |
| 2026-06-02 | -6.09 |
| 2026-06-01 | -6.42 |
| 2026-05-29 | -6.75 |
| 2026-05-28 | -6.09 |
| 2026-05-27 | -6.42 |
| 2026-05-26 | -6.42 |
| 2026-05-25 | -7.07 |
| 2026-05-22 | -6.75 |
| 2026-05-21 | -6.75 |
| 2026-05-20 | -6.42 |
| 2026-05-19 | -7.07 |
| 2026-05-18 | -7.40 |
| 2026-05-15 | -8.06 |
| 2026-05-14 | -8.06 |
| 2026-05-13 | -7.73 |
| 2026-05-12 | -8.06 |
| 2026-05-11 | -8.71 |
| 2026-05-08 | -8.71 |
| 2026-05-07 | -8.71 |
| 2026-05-01 | -8.71 |
| 2026-04-30 | -9.04 |
| 2026-04-28 | -9.37 |
| 2026-04-27 | -9.04 |
| 2026-04-24 | -9.70 |
| 2026-04-23 | -10.02 |
| 2026-04-22 | -10.35 |
| 2026-04-21 | -11.01 |
| 2026-04-20 | -11.66 |
| 2026-04-17 | -10.68 |
| 2026-04-16 | -10.02 |
| 2026-04-15 | -9.37 |
| 2026-04-14 | -9.37 |
| 2026-04-13 | -9.04 |
| 2026-04-10 | -9.37 |
| 2026-04-09 | -9.37 |
| 2026-04-08 | -9.70 |
| 2026-04-07 | -9.37 |
| 2026-04-06 | -9.37 |
| 2026-04-03 | -9.37 |
| 2026-04-02 | -10.35 |
| 2026-04-01 | -8.71 |
| 2026-03-31 | -8.38 |
| 2026-03-30 | -9.04 |
| 2026-03-27 | -9.04 |
| 2026-03-26 | -9.04 |
| 2026-03-25 | -8.38 |
| 2026-03-24 | -8.06 |